Denong Wang

denong-wang-bio-pic
Distinguished Scientist and Senior Program Director, Tumor Glycomics Laboratory, Biosciences Division

Denong Wang, Ph.D., has long-term research interest in the carbohydrate moieties that are critical for self/non-self-recognition and induction of antibody responses.

Wang and his team specialize in exploring the diversity of glycomes to identify potential new treatments for cancer and viral diseases. Wang’s laboratory was part of a National Cancer Institute network launched in 2008 to conduct glycomics research. The team has established multiple platforms of carbohydrate microarrays and introduced these glycomics tools to explore the structural and antigenic diversities of the glycome. The main research focus of his lab is on the immunogenic sugar moieties. In the past few years, his group has contributed to the identification of immunologically potent glycan markers of SARS-CoV, Bacillus anthracis exosporium, and several human cancers.

Wang received his Ph.D. in immunology and glycobiology with the late Professor Elvin A. Kabat at Columbia University in 1993. After that, he entered the developing field of post-genomics research. Before joining SRI in 2010, he served as head of the Functional Genomics Division at Columbia University’s Genome Center from 1998 to 2003 and was director of Stanford University’s Tumor Glycome Laboratory from 2007 to 2010.

Recent publications

Read more


Read more from SRI